Back to Search Start Over

5-HT2A-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis

Authors :
Tommaso Bonfiglio
Beatrice Garrone
Mario Marchi
Massimo Grilli
Cristina Padolecchia
Anna Pittaluga
Francesco Paolo Di Giorgio
Guendalina Olivero
Cesare Usai
Serena Tongiani
Matteo Vergassola
Source :
Neuropharmacology 133 (2018): 429–439. doi:10.1016/j.neuropharm.2018.02.030, info:cnr-pdr/source/autori:Olivero G, Grilli M, Vergassola M, Bonfiglio T, Padolecchia C, Garrone B, Di Giorgio FP, Tongiani S, Usai C, Marchi M, Pittaluga A/titolo:5-HT2A-mGlu2%2F3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2A to mGlu2%2F3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis/doi:10.1016%2Fj.neuropharm.2018.02.030/rivista:Neuropharmacology/anno:2018/pagina_da:429/pagina_a:439/intervallo_pagine:429–439/volume:133
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Abstract

Presynaptic mGlu2/3 autoreceptors exist in rat spinal cord nerve terminals as suggested by the finding that LY379268 inhibited the 15 mM KCl-evoked release of [H-3]D-aspartate ([H-3]D-Asp) in a LY341495-sensitive manner. Spinal cord glutamatergic nerve terminals also possess presynaptic release regulating 5-HT2A heteroreceptors. Actually, the 15 mM KCl-evoked [H-3]D-Asp exocytosis from spinal cord synaptosomes was reduced by the 5-HT2A agonist (+/-)DOI, an effect reversed by the 5-HT2A antagonists MDL11,939, MDL100907, ketanserin and trazodone (TZD). We investigated whether mGlu2/3 and 5-HT2A receptors colocalize and cross-talk in these terminals and if 5-HT2A ligands modulate the mGlu2/3-mediated control of glutamate exocytosis. Western blot analysis and confocal microscopy highlighted the presence of mGlu2/3 and 5-HT2A receptor proteins in spinal cord VGLUT1 positive synaptosomes, where mGlu2/3 and 5-HT2A receptor immunoreactivities largely colocalize. Furthermore, mGlu2/3 immunoprecipitates from spinal cord synaptosomes were also 5-HT2A immunopositive. Interestingly, the 100 pM LY379268-induced reduction of the 15 mM MCI-evoked [H-3]D-Asp overflow as well as its inhibition by 100 nM (+/-)DOI became undetectable when the two agonists were concomitantly added. Conversely, 5-HT2A antagonists (MDL11,939, MDL100907, ketanserin and TZD) reinforced the release-regulating activity of mGlu2/3 autoreceptors. Increased expression of mGlu2/3 receptor proteins in synaptosomal plasmamembranes paralleled the gain of function of the mGlu2/3 autoreceptors elicited by 5-HT2A antagonists. Based on these results, we propose that in spinal cord glutamatergic terminals i) mGlu2/3 and 5-HT2A receptors colocalize and interact one each other in an antagonist-like manner, ii) 5-HT2A antagonists are indirect positive allosteric modulator of mGlu2/3 autoreceptors controlling glutamate exocytosis. (C) 2018 Elsevier Ltd. All rights reserved.

Details

ISSN :
00283908
Volume :
133
Database :
OpenAIRE
Journal :
Neuropharmacology
Accession number :
edsair.doi.dedup.....948202ec4083483154d0530be47bea0b